Changes in vitamin D supplement use and baseline plasma 25-hydroxyvitamin D concentration predict 5-y change in concentration in postmenopausal women.

Few studies have prospectively examined predictors of change in plasma concentrations of 25-hydroxyvitamin D [25(OH)D]. We sought to determine the predictors of 5-y change in 25(OH)D. Plasma 25(OH)D concentrations were assessed at baseline (1997-2000) and 5 y later (2002-2005) in 668 postmenopausal women enrolled in the Osteoporosis and Periodontal Disease Study. Baseline and changes in demographic, dietary, lifestyle, and health-related factors were tested as predictors of change in 25(OH)D concentrations by using multivariable linear regression. The mean 5-y change in 25(OH)D (mean ± SD) was 7.7 ± 0.7 nmol/L (P < 0.001). In our predictive model (n = 643), predictors explained 31% of the variance in change in 25(OH)D concentrations and included baseline 25(OH)D, baseline and change in vitamin D supplementation and physical activity, change in season of blood draw, BMI, whole-body T score, and baseline hormone therapy use. Baseline 25(OH)D and change in vitamin D supplementation explained the most variation (25%) in 25(OH)D. Exploratory analyses showed a borderline significant interaction between tertiles of baseline 25(OH)D and change in vitamin D supplementation over time (P = 0.06). The greatest mean increase in 25(OH)D (22.9 ± 16.8 nmol/L), with adjustment for other statistically significant predictors, occurred in women whose baseline 25(OH)D concentration was ≤51.0 nmol/L (tertile 1) and who increased supplementation use over time. These results confirm the importance of supplementation in increasing 25(OH)D concentrations in aging women, even after other statistically significant predictors are controlled for. These data also suggest that this is especially true among aging women with inadequate 25(OH)D (e.g., <50 nmol/L).

[1]  D. Viswanath,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.

[2]  R. Genco,et al.  Intraindividual Variation in Plasma 25-Hydroxyvitamin D Measures 5 Years Apart among Postmenopausal Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[3]  J. Barrett,et al.  The determinants of serum vitamin D levels in participants in a melanoma case–control study living in a temperate climate , 2011, Cancer Causes & Control.

[4]  F. Agakov,et al.  Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient. , 2011, The Journal of nutrition.

[5]  A. McTiernan,et al.  Effects of weight loss on serum vitamin D in postmenopausal women. , 2011, The American journal of clinical nutrition.

[6]  Melissa A. Kluczynski,et al.  Duration of physical activity and serum 25-hydroxyvitamin D status of postmenopausal women. , 2011, Annals of epidemiology.

[7]  M. McDowell,et al.  Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). , 2011, NCHS data brief.

[8]  P. Kraft,et al.  Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis , 2011, Journal of Neurology.

[9]  R. Genco,et al.  Clinical and community risk models of incident tooth loss in postmenopausal women from the Buffalo Osteo Perio Study. , 2010, Community dentistry and oral epidemiology.

[10]  L. Blizzard,et al.  Not a simple fat‐soluble vitamin: changes in serum 25‐(OH)D levels are predicted by adiposity and adipocytokines in older adults , 2010, Journal of internal medicine.

[11]  A. LaCroix,et al.  Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. , 2010, The American journal of clinical nutrition.

[12]  R. Jorde,et al.  Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. , 2010, American journal of epidemiology.

[13]  R. Hayes,et al.  Long-term Variation in Serum 25-Hydroxyvitamin D Concentration among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[14]  R. Ortega,et al.  Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren , 2010, European Journal of Clinical Nutrition.

[15]  J. Blum,et al.  Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. , 2009, The Journal of nutrition.

[16]  L. Foo,et al.  Relationship between vitamin D status, body composition and physical exercise of adolescent girls in Beijing , 2009, Osteoporosis International.

[17]  Elizabeth A Yetley,et al.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.

[18]  A. Norman.  A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population. , 2008, The American journal of clinical nutrition.

[19]  C. Camargo,et al.  Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. , 2008, American journal of epidemiology.

[20]  J. Norris,et al.  Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. , 2008, The Journal of clinical endocrinology and metabolism.

[21]  D. Reid,et al.  Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. , 2008, Bone.

[22]  B. Dawson-Hughes,et al.  Body Size and Serum 25 Hydroxy Vitamin D Response to Oral Supplements in Healthy Older Adults , 2008, Journal of the American College of Nutrition.

[23]  S. Poppitt,et al.  Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity , 2008, Nutrition Journal.

[24]  J. Vidal,et al.  Vitamin D, PTH, and the Metabolic Syndrome in Severely Obese Subjects , 2008, Obesity surgery.

[25]  A. Wolk,et al.  Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. , 2007, The American journal of clinical nutrition.

[26]  Kazutoshi Nakamura,et al.  Age-related decrease in serum 25-hydroxyvitamin D concentrations in the frail elderly: a longitudinal study , 2007, Journal of Bone and Mineral Metabolism.

[27]  R. Heaney,et al.  Vitamin D Status in a Rural Postmenopausal Female Population , 2006, Journal of the American College of Nutrition.

[28]  R. Rizzoli,et al.  Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study , 2006, International journal of clinical practice.

[29]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[30]  P. Vestergaard,et al.  Vitamin D and its binding protein Gc: Long‐term variability in peri‐ and postmenopausal women with and without hormone replacement therapy , 2006, Scandinavian journal of clinical and laboratory investigation.

[31]  M. Trevisan,et al.  The Association Between Osteoporosis and Alveolar Crestal Height in Postmenopausal Women. , 2005, Journal of periodontology.

[32]  H. Schulz,et al.  Role of Endocytosis in Cellular Uptake of Sex Steroids , 2005, Cell.

[33]  I. Reid,et al.  Determinants of vitamin D status in older women living in a subtropical climate , 2005, Osteoporosis International.

[34]  M. Holick,et al.  Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[35]  C. Mølgaard,et al.  Teenage girls and elderly women living in northern Europe have low winter vitamin D status , 2005, European Journal of Clinical Nutrition.

[36]  Á. Balogh,et al.  Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women , 2004, Osteoporosis International.

[37]  E. Giovannucci,et al.  Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer , 2004, Cancer Causes & Control.

[38]  Garnet L Anderson,et al.  The Women's Health Initiative recruitment methods and results. , 2003, Annals of epidemiology.

[39]  Scott Davis,et al.  Implementation of the Women's Health Initiative study design. , 2003, Annals of epidemiology.

[40]  Mark Helfand,et al.  Screening for Postmenopausal Osteoporosis: A Review of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[41]  M. Cogswell,et al.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.

[42]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[43]  A. Kristal,et al.  Measurement characteristics of the Women's Health Initiative food frequency questionnaire. , 1999, Annals of epidemiology.

[44]  P. Wilson,et al.  Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. , 1997, The American journal of clinical nutrition.

[45]  B. Dawson-Hughes,et al.  Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. , 1995, The American journal of clinical nutrition.

[46]  L. Bouter,et al.  Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. , 1995, The Journal of clinical endocrinology and metabolism.

[47]  R. Wallace,et al.  Parameters related to 25-OH-D levels in a population-based study of women. , 1986, The American journal of clinical nutrition.

[48]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[49]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.